DK141550B - METHOD OF ANALOGY FOR THE PREPARATION OF ANTHELMINTIC ACTIVE 2-CARBALCOXYAMINO5 (6) -PHENYL-SULPHONYLOXY-BENZIMIDAZOLES - Google Patents
METHOD OF ANALOGY FOR THE PREPARATION OF ANTHELMINTIC ACTIVE 2-CARBALCOXYAMINO5 (6) -PHENYL-SULPHONYLOXY-BENZIMIDAZOLES Download PDFInfo
- Publication number
- DK141550B DK141550B DK419876AA DK419876A DK141550B DK 141550 B DK141550 B DK 141550B DK 419876A A DK419876A A DK 419876AA DK 419876 A DK419876 A DK 419876A DK 141550 B DK141550 B DK 141550B
- Authority
- DK
- Denmark
- Prior art keywords
- benzimidazole
- carbomethoxyamino
- phenylsulfonyloxy
- benzimidazoles
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
(11) FREMLÆ66ELSESSKJUFT 1 k 1 550 DANMARK (51) Int Cl3 c 07 D 235/32 (21) Ansagnlng nr. 4198/76 (22) Indleveret den 17· 6βρ. 1976 Ηί8π (23) Ubed8e 17# eep' ^76(11) SUPPLY POWER 1 k 1 550 DENMARK (51) Int Cl3 c 07 D 235/32 (21) Application No. 4198/76 (22) Filed on 17 · 6βρ. 1976 Ηί8π (23) Ubed8e 17 # eep '^ 76
\/ (44) Ansegningen fremtogt og , Q\ / (44) The claim made and, Q
frsmlæggelsasskriftet offentSgBjort den 21. apr. »9θϋthe publication of the writ was published on 21 April. "9θϋ
DIREKTORATET FORDIRECTORATE OF
PATENT-OG VAREMÆRKEVÆSENET (30) Prioritet begsaret fra denPATENT AND TRADEMARKET (30) Priority granted from it
19· sep. 1975# 2541752, DE19 · sep. 1975 # 2541752, DE
<71) HOECHST AKTIENGESELLSCHAFT, Brueningstrasse 45, 6230 Frankfurt/Main 80, m.<71) HOECHST AKTIENGESELLSCHAFT, Brueningstrasse 45, 6230 Frankfurt / Main 80, m.
(72) Opfinder: Heinz Loevie, Kelkheitn/Taunus, Berliner Ring 6, DE: Josef Urbanletz, SchwaTbacb/Taunus, -Am Sandring 4-4, DE: Dieter Duevtel, Hof« Heim/Taunus, Frankfurter Strasse 39/ DE: Reinhard Kirsch,~Niederjosbach/ Taunus, Kurmainzerstrasse 10, DE.(72) Inventor: Heinz Loevie, Kelkheitn / Taunus, Berlin Ring 6, DE: Josef Urbanletz, SchwaTbacb / Taunus, -Am Sandring 4-4, DE: Dieter Duevtel, Hof «Heim / Taunus, Frankfurter Strasse 39 / DE: Reinhard Kirsch, ~ Niederjosbach / Taunus, Kurmainzerstrasse 10, DE.
(74) Fuldmægtig under sagens behandling:(74) Plenipotentiary in the proceedings:
Ingeniørfirmaet Budde, Schou & Co._ (64) Analogifremgangsmåde til fremstilling af anthelmintisk virksomme 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazoler.The engineering company Budde, Schou & Co._ (64) Analogous process for the preparation of anthelmintically active 2-carbalkoxyamino-5 (6) -phenylsulfonyloxy-benzimidazoles.
2-Carbalkoxy-amino-benzimidazolylderivater med alkyl-, acyl-, phenoxy- og phenylthiogrupper i 5(6)-stilling er kendt som anthelmin-tika (P.Actor et al.. Nature 215, 321 (1967), tysk offentliggørelses-skrift nr. 2.029.637, 2.164.690 og 2.363.348).2-Carbalkoxy-amino-benzimidazolyl derivatives having alkyl, acyl, phenoxy and phenylthio groups in the 5 (6) position are known as anthelmintics (P.Actor et al., Nature 215, 321 (1967), German Publication No. Written Nos. 2,029,637, 2,164,690 and 2,363,348).
Opfindelsen angår en analogifremgangsmåde til fremstilling af hidtil ukendte anthelmintisk virksomme 2-carbalkoxyamino-S(6)--phenylsulfonyloxy-benzimidazoler med formlen IThe invention relates to an analogous process for the preparation of novel anthelmintically active 2-carbalkoxyamino-S (6) -phenylsulfonyloxy-benzimidazoles of formula I
r2 S°2 0 (I)r2 S ° 20 0 (I)
IT HIT H
2 1415 50 1 2 3 hvori R betyder en alkylgruppe med 1-4 carbonatomer, og R og R hverWherein R is an alkyl group of 1-4 carbon atoms and R and R are each
især uafhængigt af hinanden betyder hydrogenatomer, hydroxyIgrupper, alkoxygrupper med 1-4 carbonatomer, halogenatomer, trifluormethylgrupper, alkyIgrupper med 1-4 carbonatomer, carbalkoxygrupper med 1-4 carbonatomer i alkoxygruppen eller cyanogrupper, hvilken fremgangsmåde er ejendommelig ved, at et 2-carbalkoxyamino-5(6)-hydroxybenzimidazol med formlen IIespecially independently of one another, hydrogen atoms, hydroxy groups, alkoxy groups of 1-4 carbon atoms, halogen atoms, trifluoromethyl groups, alkyl groups of 1-4 carbon atoms, carbalkoxy groups of 1-4 carbon atoms in the alkoxy group or cyano groups, which process is characterized by a 2-carboxyalkyl 5 (6) -hydroxybenzimidazole of formula II
“'CO'*"' ”“'CO' *" '"
hvori R·*· har den samme betydning som i formel I, omsættes med et benzensulfonsyrehalogenid med formlen IIIwherein R · * · has the same meaning as in Formula I, is reacted with a benzenesulfonic acid halide of Formula III
^0-S02x (III) 2 3 hvori R og R har den samme betydning som i formel I, og X betyder et fluor-, chlor- eller bromatom, i nærværelse af en base. Til omsætningen foretrækkes benzensulfonsyrechlorider med formlen III.Wherein R and R have the same meaning as in formula I and X represents a fluorine, chlorine or bromine atom, in the presence of a base. For the reaction, benzene sulfonic acid chlorides of formula III are preferred.
12 3 I betragtning som alkylgrupper R , R og R kommer methyl-, ethyl-, propyl-, isopropyl-, butyl-, sek.butyl·og tert.butyIgrupper.12 3 Considering alkyl groups R, R and R are methyl, ethyl, propyl, isopropyl, butyl, sec-butyl and tert-butyl groups.
2 3 I betragtning som alkoxygrupper R og R kommer methoxy-, ethoxy-, propoxy-, isopropoxy- og butoxygrupper. I betragtning som halogenatomer 2 3 R og R kommer fluor-, chlor-, brom- og iodatomer. I betragtning som 2 3 carbalkoxygrupper R og R kommer carbomethoxy-, carbethoxy-, carboprop-oxy- eller carbobutoxygrupper.2 3 Considering alkoxy groups R and R come methoxy, ethoxy, propoxy, isopropoxy and butoxy groups. Considering halogen atoms 2 3 R and R come fluorine, chlorine, bromine and iodine atoms. Considering that 2 3 carbalkoxy groups R and R come carbomethoxy, carbethoxy, carboprop oxy or carbobutoxy groups.
Særlig foretrukne er forbindelser med formlen I, hvori R^ be- 2 tyder en methyl-, ethyl-, propyl- eller butylgruppe, R betyder et 3 hydrogenatom eller et chloratom, og R betyder et hydrogenatom, et chloratom eller en trifluormethylgruppe.Particularly preferred are compounds of formula I wherein R 2 represents a methyl, ethyl, propyl or butyl group, R represents a 3 hydrogen atom or a chlorine atom, and R represents a hydrogen atom, a chlorine atom or a trifluoromethyl group.
Reaktionsforløbet er vist ved følgende skema 3 141550 + “iQ^^Sc-NH-COOR1 r3'2 I ^^-ir ^X>^°nø(>wThe course of the reaction is shown by the following scheme 3 141550 + "iQ ^^ Sc-NH-COOR1 r3'2 I ^^ - ir ^ X> ^ ° no (>
HH
Til gennemførelse af reaktionen suspenderes et 2-carbalkoxy-amino-5(6)-hydroxy-benzimidazol med formlen II i et aprotisk opløsningsmiddel med en tertiær amin, og under omrøring tildtyppes en opløsning af et benzensulfonsyrehalogenid med formlen III. Blandingen omrøres, indtil omsætningen er tilendebragt, idet dette tidspunkt hensigtsmæssigt bestemmes ved tyndtlagschromatografisk kontrol.To carry out the reaction, a 2-carbalkoxy-amino-5 (6) -hydroxy-benzimidazole of formula II is suspended in an aprotic solvent with a tertiary amine, and with stirring, a solution of a benzenesulfonic acid halide of formula III is added. The mixture is stirred until the reaction is complete, which time is conveniently determined by thin layer chromatographic control.
Som aprotiske opløsningsmidler kan der nævnes acetone, tetra-hydrofuran, dioxan, diethylether, diisopropylether, dimethylformamid, dimethylsulfoxid, tetramethylurinstof og lignende, dipolære, aprotiske opløsningsmidler.As aprotic solvents there may be mentioned acetone, tetrahydrofuran, dioxane, diethyl ether, diisopropyl ether, dimethylformamide, dimethylsulfoxide, tetramethylurea and the like, dipolar aprotic solvents.
På tale som baser kommer alkalimetal- eller jordalkalimetal*-hydroxider, -carbonater og -hydrogencarbonater eller tertiære organiske baser. Som eksempler herpå kan der nævnes natriumhydroxid, natriuw-hydrogencarbonat, natriumcarbonat, kaliumcarbonat, kaliumhydrogencar-bonat, triethylamin, pyridin og methylsubstituerede pyridiner.Speaking as bases come alkali metal or alkaline earth metal * hydroxides, carbonates and hydrogen carbonates or tertiary organic bases. Examples include sodium hydroxide, sodium hydrogen carbonate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, triethylamine, pyridine and methyl-substituted pyridines.
Reaktionens temperaturområde ligger mellem 0 og 60°C, fortrinsvis mellem 15 og 30°C. Omsætningens hastighed afhænger af det anvendte benzensulfonsyrechlorids reaktionsevne, således at varigheden kan variere fra nogle få timer til et døgn.The temperature range of the reaction is between 0 and 60 ° C, preferably between 15 and 30 ° C. The rate of the reaction depends on the reactivity of the benzenesulfonic acid chloride used, so that the duration can vary from a few hours to a day.
Reaktionens forløb kan følges ved tyndtlagschromatografisk kontrol, idet der hensigtsmæssigt anvendes silicagel som adsorbéns og blandinger af chloroform, eddikesyreethylester og iseddike, fortrinsvis i forholdet 10:10:1, som løbemiddel.The course of the reaction can be followed by thin layer chromatographic control, suitably using silica gel as the adsorbent and mixtures of chloroform, acetic acid ethyl ester and glacial acetic acid, preferably in the ratio of 10: 10: 1, as the solvent.
Reaktionsprodukterne isoleres fra reaktionsblandingen ved filtrering.The reaction products are isolated from the reaction mixture by filtration.
4 1415504 141550
Det som udgangsmateriale anvendte 2-carbalkoxyamino-5(6)-hydro-xybenzimidazol med formlen II fremstilles ved kendte metoder (jf. tysk offentliggørelsesskrift nr. 2.164.690). Således omsættes 3-nitro--4-aminophenol med benzoylchlorid til benzoesyre-3-nitro-4-amino-pheny1-ester, denne forbindelse hydrogeneres med Raney-nikkel til 3,4-diamino-derivater og dette omsættes med S-methyl-thiourinstofcarboxylat til 2-carbalkoxyamino-5-benzoyloxy-benzimidazol, hvoraf hydroxyforbindelsen med formlen II fås med fortyndet natriumhydroxidopløsning.The 2-carbalkoxyamino-5 (6) -hydro-xybenzimidazole of formula II used as starting material is prepared by known methods (cf. German Publication No. 2,164,690). Thus, 3-nitro-4-aminophenol is reacted with benzoyl chloride to benzoic acid 3-nitro-4-amino-phenyl ester, this compound is hydrogenated with Raney nickel to 3,4-diamino derivatives and this is reacted with S-methyl thiourea carboxylate for 2-carbalkoxyamino-5-benzoyloxy-benzimidazole, of which the hydroxy compound of formula II is obtained with dilute sodium hydroxide solution.
De her omhandlede 2-carbalkoxyamino-5(6)-phenylsulfonyloxy--benzimidazoler er værdifulde kemoterapeutika og egner sig til bekæmpelse af parasitsygdomme hos mennesker og dyr, f.eks. fremkaldt af helminther og leverikter. De er særlig virksomme mod et stort antal helminther, f.eks. Haemonchus, Trichostrongylus, Ostertagia, Stron-gyloides, Cooperia, Chabertia, Oesophagostomum, Hyostrongylus, Ankylostoma, Askaris og Heterakis. Særlig udpræget er virkningen over for mave-tarm-strongylider, som frem for alt angriber drøvtyggere.The 2-carbalkoxyamino-5 (6) -phenylsulfonyloxy-benzimidazoles disclosed herein are valuable chemotherapeutics and are useful in the control of parasitic diseases in humans and animals, e.g. induced by helminther and livery. They are particularly effective against a large number of helminths, e.g. Haemonchus, Trichostrongylus, Ostertagia, Stron gyloides, Cooperia, Chabertia, Oesophagostomum, Hyostrongylus, Ankylostoma, Askaris and Heterakis. Particularly pronounced is the effect on gastrointestinal strongylids, which primarily attack ruminants.
Angreb på dyr af disse parasitter fører til store økonomiske skader, hvorfor de her omhandlede forbindelser især finder anvendelse i ve t erinærlægemi dier.Attacks on animals of these parasites lead to great economic damage, which is why the compounds in question are particularly useful in veterinary medicine.
De virksomme stoffer med formel I indgives afhængigt af tilfældets situation i doseringer mellem 0,5 og 50 mg pr. kg legemsvægt i 1-14 dage.The active substances of formula I are administered depending on the situation of the case in doses between 0.5 and 50 mg per day. kg body weight for 1-14 days.
I et sammenligningsforsøg er der anvendt den nærmest liggende af de kendte 5 (-6)-substituerede 2-benzimidazolcarbaminater, nemlig det såkaldte "Oxfendazol", der er 5(6)-phenylsulfinyl-2--carbomethoxyaminobenzimidazol, og en række af de i de følgende eksempler fremstillede forbindelser. Forsøgene udførtes på den måde, at lam oralt fik 200 metacercarier af Fasciola hepatica, og efter udløbet af præpatenstiden sikrede man sig koprologisk, at der var fremkommet en infektion. Efter behandling af dyrene med forsøgsforbindelserne konstaterede resultaterne ved gentagne fæcesundersøgelser og til sidst ved dissektion. Nedenfor er anført de peroralt indgivne doser og udryddelsen af parasitterne.In a comparison experiment, the closest of the known 5 (-6) -substituted 2-benzimidazole carbaminates, namely the so-called "Oxfendazole" which is 5 (6) -phenylsulfinyl-2-carbomethoxyaminobenzimidazole, and a number of the The following examples prepared compounds. The experiments were carried out in such a way that lamb received orally 200 metacercariae of Fasciola hepatica, and after the expiry of the prepathetic period, there was a headache to ensure that an infection had occurred. After treatment of the animals with the test compounds, the results were obtained by repeated faecal examinations and eventually by dissection. Listed below are the oral doses and the eradication of the parasites.
5 14155Ό5 14155Ό
Forb. Fasciola/lam Udryddelse iflg. eks. mgA<? Ρ·ο·____%__ 1 1 x 50 100 2 1 x 50 100 3 1 x 50 100 4 1 x 30 100 5 1 x 50 100 6 1 x 30 80 7 1 x 50 100 8 1 x 50 100 9 1 x 10 100 10 1 x 30 100 11 1 x 30 100 12 _1 x 50_100_ "Oxfendazol" 1 x 30 0Conn. Fasciola / lamb Extinction according to. eg mgA <? Ρ · ο · ____% __ 1 1 x 50 100 2 1 x 50 100 3 1 x 50 100 4 1 x 30 100 5 1 x 50 100 6 1 x 30 80 7 1 x 50 100 8 1 x 50 100 9 1 x 10 100 10 1 x 30 100 11 1 x 30 100 12 _1 x 50_100_ "Oxfendazole" 1 x 30 0
De her omhandlede produkter er ikke kun udmærket virksomme ved oral indgivelse, men virker også parenteralt i doseringer på ned til 2 mg/kg. Dermed er de langt overlegne i forhold til sammenlignelige benzimidazolderivater, især alle kendte 5(6)-substituerede 2-benzimidazol-carbaminater.The products of this invention are not only very effective in oral administration, but also act parenterally in doses of up to 2 mg / kg. Thus, they are far superior to comparable benzimidazole derivatives, especially all known 5 (6) -substituted 2-benzimidazole carbaminates.
Eksempel 1.Example 1.
5,15 g 2-carbomethoxyamino-5 (6)-hydroxy-benzimidazol suspen«· deres i 100 ml acetone, og der tilsættes 3,5 ml triethylamin. Under kraftig omrøring tildryppes der ved stuetemperatur en opløsning af 4,4 g benzensulfonsyrechlorid i 20 ml acetone og omrøres i 10 timer, hvorved suspensionens konsistens ændres tydeligt. Den bliver først tyndtflydende og derefter gradvis tyk igen. Efter afkøling frafiltrerés de faste bestanddele, der vaskes successivt med acetone, vand og methanol og tørres på dampbad.5.15 g of 2-carbomethoxyamino-5 (6) -hydroxy-benzimidazole are suspended in 100 ml of acetone and 3.5 ml of triethylamine is added. With vigorous stirring, a solution of 4.4 g of benzenesulfonic acid chloride in 20 ml of acetone is added dropwise at room temperature and stirred for 10 hours, thereby changing the consistency of the suspension clearly. It first gets thin and then gradually thick again. After cooling, the solid components which are successively washed with acetone, water and methanol are filtered off and dried on a steam bath.
Til rensning omkrystalliseres råproduktet fra iseddike/methanol. Udbyttet af 2-carbomethoxyamino-5(6)-phenylsulfonyloxy-benzimidazol er 6,2 g med et sønderdelingspunkt på 242°C. Den tyndt lags chroma tografiske kontrol af reaktionsblandingen på silicagel med en blanding af 10 ml chloroform, 10 ml eddikesyreethylester og 1 ml iseddike som løbemiddel 6For purification, the crude product from glacial acetic acid / methanol is recrystallized. The yield of 2-carbomethoxyamino-5 (6) -phenylsulfonyloxy-benzimidazole is 6.2 g with a decomposition point of 242 ° C. The thin layer chromatographic control of the reaction mixture on silica gel with a mixture of 10 ml of chloroform, 10 ml of acetic acid ethyl ester and 1 ml of glacial acetic acid as a solvent 6
MlBffQMlBffQ
viser, at. udgangsmaterialets plet er forsvundet, og at reaktionsproduktet med en højere R^-værdi er trådt i stedet.shows that. the spot of the starting material has disappeared and the reaction product with a higher R
Analogt hermed fremstilles der under anvendelse af ækvivalente mængder af de tilsvarende benzensulfonsyrechlorider ud fra 5,15 g 2-carbomethoxyamino-5(6)-hydroxy-benzimidazol og 2) 5,3 g 4-chlor-benzensulfonsyrechlorid 6.8 g 2-carbomethoxyamino-5($)-(4-chlor-phenylsulfonyloxy-)- benzimidazol med smp. 230°C (sønderdeling) 3) 5,3 g 3-chlor-benzensulfonsyrechlorid 6.8 g 2-carbomethoxyamino-5(6)-(3-chlor-phenylsulfonyloxy)- benzimidazol med smp. 250° (sønderdeling) 4) 6,15 g.3,4-dichlor-benzensulfonsyrechlorid 7,4 g 2-carbomethoxyamino-5(6)-(3,4-dichlor-phenylsulfonyloxy)-benzimidazol med smp. 255°C (sønderdeling) 5) 6,15 3,5-dichlor-benzensulfonsyrechlorid 7.3 g 2-carbomethoxyamino-5(6)-(3,5-dichlor-phenylsulfonyloxy)- benzimidazol med smp. 280°C (sønderdeling) 6) 6,4 g 3-brom-benzensulfonsyrechlorid 7,6 g 2-carbomethoxyamino-5(6)-(3-brom-phenylsulfonyloxy)-benzimidazol med smp. 242°C (sønderdeling) 7) 4,8 g 4-methyl-benzensulfonsyrechlorid 6.4 g 2-carbomethoxyamino-5(6)-(4-methyl-phenylsulfonyloxy)- benzimidazol med smp. 237°C (sønderdeling) 8) 4,8 g 3-methyl-benzensu'lfonsyrechlorid 6.4 g 2-carbomethoxyamino-5(6)-(3-methyl-phenylsulfonyloxy)- benzimidazol med smp. 250°C (sønderdeling) 9) 6,1 g 3-trifluormethyl-benzensulfonsyrechlorid 7.4 g 2-carbomethoxyamino-5(6)-(3-trifluormethyl-phenylsulfo- nyloxy) -benzimidazol med smp. 215°C (sønderdeling) og under anvendelse af 6,1 g 3-trifluormethyl-benzensulfonsyrechlorid og 10) 5,5 g 2-carbethoxyamino-5(6)-hydroxy-benzimidazol 7,7 g 2-carbethoxyamino-5(6)-(3-trifluormethyl-phenylsulfo-nyloxy)-benzimidazol med smp. 227°C (sønderdeling) 11) 5,9 g 2-carbisopropoxyamino-5(6)-hydroxy-benzimidazol 8,0 g 2-carbisopropoxyamino-5(6)-(3-trifluormethyl-phenylsul-fonyloxy)-benzimidazol med smp. 205°C (sønderdeling) 141550 7 12) 6/2 g 2-carbisobutoxyamlno-5(6)-hydroxy-benzimidazol 8,2 g 2-carbisobutoxyamino-5(6)-(3-trifluormethyl-phenylsul-fonyloxy)-benzimidazol med smp. 243°C (sønderdeling) 13) 5,1 g 3-cyano-benzosulfonsyrechlorid 6,7 g 2-carbomethoxyamino-5(6)-(3-cyano-phenylsulfonyloxy)-benzimidazol med smp. 275°C (sønderdeling)By analogy, equivalent amounts of the corresponding benzenesulfonic acid chlorides are prepared from 5.15 g of 2-carbomethoxyamino-5 (6) -hydroxy-benzimidazole and 2) 5.3 g of 4-chlorobenzene-sulfonic acid chloride 6.8 g of 2-carbomethoxyamino-5 ($) - (4-Chloro-phenylsulfonyloxy -) - benzimidazole, m.p. 230 ° C (dec.) 3) 5.3 g of 3-chlorobenzene sulfonic acid chloride 6.8 g of 2-carbomethoxyamino-5 (6) - (3-chloro-phenylsulfonyloxy) -benzimidazole, m.p. 250 ° (decomposition) 4) 6.15 g of 3,4-dichloro-benzenesulfonic acid chloride 7.4 g of 2-carbomethoxyamino-5 (6) - (3,4-dichloro-phenylsulfonyloxy) -benzimidazole, m.p. 255 ° C (dec.) 5) 6.15 3,5-Dichlorobenzene sulfonic acid chloride 7.3 g of 2-carbomethoxyamino-5 (6) - (3,5-dichlorophenylsulfonyloxy) -benzimidazole, m.p. 280 ° C (dec.) 6) 6.4 g of 3-bromo-benzenesulfonic acid chloride 7.6 g of 2-carbomethoxyamino-5 (6) - (3-bromo-phenylsulfonyloxy) -benzimidazole, m.p. 242 ° C (dec.) 7) 4.8 g of 4-methyl-benzenesulfonic acid chloride 6.4 g of 2-carbomethoxyamino-5 (6) - (4-methyl-phenylsulfonyloxy) -benzimidazole, m.p. 237 ° C (dec.) 8) 4.8 g of 3-methylbenzenesulfonic acid chloride 6.4 g of 2-carbomethoxyamino-5 (6) - (3-methyl-phenylsulfonyloxy) -benzimidazole, m.p. 250 g (decomposition) 9) 6.1 g of 3-trifluoromethyl-benzenesulfonic acid chloride 7.4 g of 2-carbomethoxyamino-5 (6) - (3-trifluoromethyl-phenylsulfonyloxy) -benzimidazole, m.p. 215 ° C (decomposition) and using 6.1 g of 3-trifluoromethyl-benzenesulfonic acid chloride and 10) 5.5 g of 2-carbethoxyamino-5 (6) -hydroxy-benzimidazole 7.7 g of 2-carbethoxyamino-5 (6) - (3-trifluoromethyl-phenylsulfonyloxy) -benzimidazole, m.p. 227 ° C (dec.) 11) 5.9 g of 2-carbisopropoxyamino-5 (6) -hydroxy-benzimidazole 8.0 g of 2-carbisopropoxyamino-5 (6) - (3-trifluoromethyl-phenylsulfonyloxy) -benzimidazole, m.p. . 205 ° C (decomposition) 12) 6/2 g of 2-carbisobutoxyamino-5 (6) -hydroxy-benzimidazole 8.2 g of 2-carbisobutoxyamino-5 (6) - (3-trifluoromethyl-phenylsulfonyloxy) -benzimidazole with m.p. 243 ° C (dec.) 13) 5.1 g of 3-cyano-benzosulfonic acid chloride 6.7 g of 2-carbomethoxyamino-5 (6) - (3-cyano-phenylsulfonyloxy) -benzimidazole, m.p. 275 ° C (dec.)
Til fremstilling af det som udgangsmateriale anvendte 2-carbo-methoxyamino-5 (6) -hydroxy-benzimidazol blandes 56 g S-methylthiourinstof-sulfat i 90 ml vand med 26 ml chlormyresyremethylester, og ved en temperatur under 20°C tildryppes der 116 g 25%*s natriumhydroxidopløsning. Der omrøres i yderligere 1/2 time og tilsættes derefter en opløsning, der er fremstillet ved hydrogenering af 51,6 g benzæ-syre-3-nitro-4-amino-phenylester i 250 ml iseddike med Raney-nikkel og filtrering fra katalysatoren. Der tilsættes 300 ml iseddike, 100 ml vand og 100 ml methanol og koges i 2 timer under tilbagesvaling.To prepare the starting material used 2-carbo-methoxyamino-5 (6) -hydroxy-benzimidazole, 56 g of S-methylthiourea sulfate is mixed in 90 ml of water with 26 ml of chloroformic acid methyl ester and 116 g is added dropwise 25% * sodium hydroxide solution. Stir for an additional 1/2 hour and then add a solution prepared by hydrogenation of 51.6 g of benzoic acid 3-nitro-4-amino-phenyl ester in 250 ml of glacial acetic acid with Raney nickel and filtration from the catalyst. Add 300 ml of glacial acetic acid, 100 ml of water and 100 ml of methanol and cook for 2 hours at reflux.
Efter afkøling isoleres det udfældede 2-carbomethoxyamino-5(6)-benzoyl-oxy-benzimidazol i et udbytte på 41 g med et smp. på 280°C (sønderdeling) .After cooling, the precipitated 2-carbomethoxyamino-5 (6) -benzoyl-oxy-benzimidazole is isolated in a yield of 41 g with a m.p. at 280 ° C (dec.).
Det således fremstillede 2-carbomethoxyamino~5(6)-benzoyloxy--benzimldazol omrøres i en blanding af 400 ml methanol og 400 ml 2 N natriumhydroxidopløsning i 5 minutter, og opløsningen filtreres, neutraliseres med iseddike og inddampes i vakuum. Til remanensen sættes 100 ml vand, og det udfældede faste stof fraskilles ved sugning og vaskes med methanol og diisopropylether. Efter omkrystallisation fra iseddike/methanol i forholdet 1:1 fås der 21 g 2-carbomethoxyamino-5(6)--hydroxy-benzimidazol med et smp. på 305°C (sønderdeling).The 2-carbomethoxyamino ~ 5 (6) -benzoyloxy-benzimldazole thus prepared is stirred in a mixture of 400 ml of methanol and 400 ml of 2N sodium hydroxide solution for 5 minutes and the solution is filtered, neutralized with glacial acetic acid and evaporated in vacuo. To the residue is added 100 ml of water and the precipitated solid is separated by suction and washed with methanol and diisopropyl ether. After recrystallization from glacial acetic acid / methanol in a 1: 1 ratio, 21 g of 2-carbomethoxyamino-5 (6) -hydroxy-benzimidazole are obtained, m.p. at 305 ° C (dec.).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2541752 | 1975-09-19 | ||
DE19752541752 DE2541752A1 (en) | 1975-09-19 | 1975-09-19 | ANTHELMINTHICALLY ACTIVE 2-CARBALCOXYAMINO-5 (6) -PHENYL-SULFONYLOXY- BENZIMIDAZOLE AND METHOD FOR THEIR PRODUCTION |
Publications (3)
Publication Number | Publication Date |
---|---|
DK419876A DK419876A (en) | 1977-03-20 |
DK141550B true DK141550B (en) | 1980-04-21 |
DK141550C DK141550C (en) | 1980-10-06 |
Family
ID=5956862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK419876A DK141550C (en) | 1975-09-19 | 1976-09-17 | METHOD OF ANALOGY FOR THE PREPARATION OF ANTHELMINTIC ACTIVE 2-CARBALCOXYAMINO-5 (6) -PHENYL-SULPHONYLOXY-BENZIMIDAZOLES |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT358575B (en) |
CA (1) | CA1069909A (en) |
CH (1) | CH619938A5 (en) |
DE (1) | DE2541752A1 (en) |
DK (1) | DK141550C (en) |
ES (1) | ES451497A2 (en) |
FI (1) | FI762653A (en) |
GR (1) | GR60799B (en) |
HU (1) | HU172484B (en) |
NO (1) | NO763196L (en) |
PT (1) | PT65607B (en) |
SE (1) | SE7610310L (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4435418A (en) * | 1982-12-13 | 1984-03-06 | Smithkline Beckman Corporation | 5-Phenylethenylbenzimidazoles |
EP1298125A1 (en) * | 2001-09-26 | 2003-04-02 | Aventis Pharma S.A. | Substituted benzimidazole compounds and their use for the treatment of cancer |
FR2868421B1 (en) | 2004-04-01 | 2008-08-01 | Aventis Pharma Sa | NOVEL BENZOTHIAZOLES AND THEIR USE AS MEDICAMENTS |
FR2891273B1 (en) | 2005-09-27 | 2007-11-23 | Aventis Pharma Sa | NOVEL BENZIMIDAZOLE AND BENZOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE, IN PARTICULAR AS CMET INHIBITORS |
-
1975
- 1975-09-19 DE DE19752541752 patent/DE2541752A1/en active Pending
-
1976
- 1976-09-14 ES ES451497A patent/ES451497A2/en not_active Expired
- 1976-09-16 HU HU76HO00001929A patent/HU172484B/en unknown
- 1976-09-16 FI FI762653A patent/FI762653A/fi not_active Application Discontinuation
- 1976-09-16 SE SE7610310A patent/SE7610310L/en unknown
- 1976-09-17 AT AT690876A patent/AT358575B/en active
- 1976-09-17 CA CA261,425A patent/CA1069909A/en not_active Expired
- 1976-09-17 NO NO763196A patent/NO763196L/en unknown
- 1976-09-17 DK DK419876A patent/DK141550C/en active
- 1976-09-17 PT PT65607A patent/PT65607B/en unknown
- 1976-09-17 CH CH1182076A patent/CH619938A5/en not_active IP Right Cessation
- 1976-09-18 GR GR51724A patent/GR60799B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK141550C (en) | 1980-10-06 |
CA1069909A (en) | 1980-01-15 |
HU172484B (en) | 1978-09-28 |
SE7610310L (en) | 1977-03-20 |
ATA690876A (en) | 1980-02-15 |
NO763196L (en) | 1977-03-22 |
FI762653A (en) | 1977-03-20 |
PT65607B (en) | 1978-05-10 |
AT358575B (en) | 1980-09-25 |
DK419876A (en) | 1977-03-20 |
CH619938A5 (en) | 1980-10-31 |
GR60799B (en) | 1978-08-30 |
DE2541752A1 (en) | 1977-03-24 |
ES451497A2 (en) | 1977-12-01 |
PT65607A (en) | 1976-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003208105B2 (en) | Aromatic amino acid derivatives and medicinal compositions | |
NO832356L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE IMIDAZOLD DERIVATIVES. | |
SE414402B (en) | SET TO MAKE ALKYL-BENZIMIDAZOLE CARBAMATES | |
US2406594A (en) | Tertiary amines of heterocyclic compounds | |
KR890000382B1 (en) | Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles | |
NO152373B (en) | ANALOGUE PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 8-PHENYL-PURINE DERIVATIVES | |
AU604771B2 (en) | Pyridinylphenylthio and pyridinylphenylsulphinyl benzimidazone derivatives | |
SU850007A3 (en) | Method of preparing imidazo /2,2-b/ derivatives | |
SU564814A3 (en) | Method for obtaining d-homosteroids | |
NO834773L (en) | SUBSTITUTED PHENYL SULPHONYLOXYBENZIMIDAZOLE CARBAMINATES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE | |
DK141550B (en) | METHOD OF ANALOGY FOR THE PREPARATION OF ANTHELMINTIC ACTIVE 2-CARBALCOXYAMINO5 (6) -PHENYL-SULPHONYLOXY-BENZIMIDAZOLES | |
NO164472B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE SUBSTITUTED 2- (MONOCONDENSED (3,4- AND 5,6) -PYRIDYLALKYLENSULPHINYL) -BENZIMIDAZOLES. | |
NO145244B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW GONA-4.9 (10) PROGESTAGEN ACTIVITIES | |
WO2012088776A1 (en) | Preparation methods of 2-(n-substituted)-amino-benzimidazole derivatives | |
US2307650A (en) | Sulphanilamido-amino-pyridines and processes for producing the same | |
NO140592B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF ANTELMINTIC ACTIVITY 2-CARBALCOXYAMINO-BENZIMIDAZOLYL-5- (6) -SULPHONIC ACID PHENYLES | |
CA1059135A (en) | Anthelmintically active 2-carbalkoxyamino-5 (6)-phenyl sulfonyloxy benzimidazoles and process for their manufacture | |
Colbry et al. | Synthesis and antimalarial properties of 2, 4‐diamino‐6‐[(aryl) thio, sulfinyl, and sulfonyl] pyrido [3, 2‐d] pyrimidines | |
JPH01117885A (en) | Novel podophyllotoxin derivative and production thereof | |
NO119270B (en) | ||
DK141166B (en) | PROCEDURE FOR PREPARING 5,6,7,7A-TETRAHYDROINDAN-5-ON DERIVATIVES OR 1,2,3,4,8,8A-HEXAHYDRO-6 (7 ') - NAFTALENON-DEDEVATER | |
US4069325A (en) | 3-Carbalkoxyamino-1H-2,1,4-benzothiadiazine derivatives | |
SU482044A3 (en) | The method of obtaining 4-or 5-nitromidazoles | |
CN115490687B (en) | 3-benzofuranyl thioimidazo pyridine derivative, preparation method and application thereof | |
NO140593B (en) | ANALOGICAL PROCEDURES FOR THE PREPARATION OF ANTELMINTIC ACTIVITY BASIC SUBSTITUTED 2-CARBALCOXYAMINO-BENZIMIDAZOLYL-5- (6) PHENYLETERS AND KETONES |